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Autophagy is important for the degradation of bulk cytoplasm, long-lived proteins, and entire organelles. In
lower eukaryotes, autophagy functions as a cell death mechanism or as a stress response during develop-
ment. However, autophagy’s significance in vertebrate development, and the role (if any) of vertebrate-
specific factors in its regulation, remains unexplained. Through careful analysis of the current autophagy
gene mutant mouse models, we propose that in mammals, autophagy may be involved in specific cytosolic
rearrangements needed for proliferation, death, and differentiation during embryogenesis and postnatal
development. Thus, autophagy is a process of cytosolic ‘‘renovation,’’ crucial in cell fate decisions.Autophagy is a lysosomal pathway used by eukaryotes for
degrading and recycling various cellular constituents, such as
long-lived proteins and entire organelles. There are three main
forms of autophagy: microautophagy, macroautophagy, and
chaperone-mediated autophagy (Klionsky, 2005; Massey et al.,
2006). Microautophagy and the mammalian-specific chaper-
one-mediated autophagy directly involve the lysosome, which
either engulfs small portionsof cytosol or receiveschaperone-as-
sociated cargoes, respectively. Macroautophagy is responsible
for the turnover of organelles andportions of cytosol sequestered
in a double-membrane-bound vesicle, the autophagosome.
Autophagosomes originate from a precursor structure, the phag-
ophore, which starts growing at both ends and finally closes and
wraps the bulk cytoplasm and organelles (Figure 1A). Autopha-
gosomes slide along cytoskeletal structures and fuse with lyso-
somes, forming a single large andmembrane-surrounded vesicle
called the autophagolysosome, where both their membrane and
contents are degraded by lytic enzymes (reviewed in Xie and
Klionsky, 2007).
Most of the genes involved in macroautophagy (hereafter au-
tophagy), the so-called Autophagy-related (Atg) genes, have
been discovered in S. cerevisiae (Ohsumi, 2001). These include
genes that regulate autophagosome formation, which requires
two evolutionarily conserved ubiquitin-like conjugation sys-
tems—the Atg12-Atg5 and the Atg8(LC3)-PE (phosphatidyletha-
nolamine) systems (Figure 1) (Ohsumi, 2001; Suzuki andOhsumi,
2007)—as well as genes that function in other stages of autoph-
agy. Atg genes were originally described in yeast, and in some
cases their orthologs have been isolated and functionally
characterized in mammals (Table 1) (Ferraro and Cecconi, 2007;
Levine and Kroemer, 2008).
A core molecule in autophagy regulation is the kinase mam-
malian Target Of Rapamycin (mTOR). By sensing signals that
monitor nutrient levels, mTOR can trigger protein translation by
specific phosphorylation of the ribosomal protein S6 kinase344 Developmental Cell 15, September 16, 2008 ª2008 Elsevier Inc(pS6K) (Blommaart et al., 1995). When nutrients are lacking,
mTOR repression shifts cellular metabolism toward autophagy
and recycling of cytosolic constituents (Figure 1), although the
precise targets of mTOR in autophagy remain unidentified.
The discovery of the molecular basis of autophagy has en-
abled the search for links with human pathological conditions.
Genetic or pharmacological alteration in this process impairs
cell survival rate or cell metabolism, thereby affecting tissue ho-
meostasis (Levine and Kroemer, 2008; Mizushima et al., 2008).
Many neurodegenerative conditions, for example, can be traced
back to defective autophagy. The role of autophagy in Hunting-
ton’s disease, Parkinson’s disease, amyotrophic lateral sclero-
sis, or Alzheimer’s disease may reside in the failure to clear
aggregates of mutated toxic proteins (reviewed in Rubinsztein,
2006). Autophagy has also been identified as a crucial process
in oncogenesis and cancer progression (Gozuacik and Kimchi,
2004; Jin and White, 2007; Levine and Kroemer, 2008; Mizush-
ima et al., 2008). Several autophagy-related proteins have tumor
suppressor activity (Beclin 1, Atg5, Bif-1, Atg4C, UVRAG), and
some autophagy gene mutations, detected in humans or in-
duced in cellular or animal models, can lead to an accumulation
of DNA damage and genome instability (Mathew et al., 2007). In
cancer progression, autophagy may, on the other hand, provide
tumor cellswith a survival strategy, thus suggesting a therapeutic
use for autophagy downregulation in solid tumors (reviewed in
Levine and Kroemer, 2008; Mizushima et al., 2008).
Further, antigen presentation, innate immune signaling, and
pathogen degradation may all involve autophagosome recruit-
ment and activity, and autophagy plays an important role in
immunity and infectious diseases (Levine and Deretic, 2007).
After Christian de Duve’s first electron-microscopy-based
description of autophagy (1963) and Per Seglen’s seminal work
on the convergence between autophagic and endocytic path-
ways (De Duve, 1963; De Duve and Wattiaux, 1966; Gordon
and Seglen, 1988), Yoshinori Ohsumi and Michael Thumm in.
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ReviewFigure 1. Autophagosome Formation in Vertebrates
(A) Autophagosomes (AF) originate from a precursor structure (phagophore), which grows, closes, and wraps the cytoplasmic components and organelles.
Eventually, the autophagosome fuses with the lysosome (Ly), forming a structure termed autophagolysosome or autolysosome (AL). The contents of the auto-
phagosome are then degraded by the lysosomal enzymes.
(B) Autophagosome nucleation is driven by phosphatidylinositol (PI) phosphorylation. This process (highlighted in blue) is mediated by a lipid kinase signaling
complex (Beclin 1, Vps15, Vps34). Ambra1 promotes Beclin 1/Vps34 interaction, whereas Ulk1 is downstream of mTOR (which is inhibitory for autophagy)
and is involved in autophagy induction (see text), although it is not a subunit of the Beclin 1/Vps34 complex. UVRAG and Bif-1 have been described as additional
regulators of the Beclin 1/Vps34 complex.
(C) Autophagosome elongation is triggered by lipid modification of LC3 (by phosphatidylethanolamine, PE), as highlighted in yellow. This process is mediated,
among others, by Atg7 (an E1-like ubiquitin conjugating enzyme), Atg3 (an E2-like ubiquitin conjugating enzyme), and Atg4C, to which LC3 is bound at first. Atg7
also acts in a ubiquitin-like conjugation system involving the E2-like ubiquitin conjugating enzyme Atg10 and Atg12/Atg5 which, at the end of the process, are
transferred to Atg16L. The complex Atg12/Atg5/Atg16L mediates LC3-PE binding to the autophagosome membranes.the early 1990s independently began a detailed analysis of au-
tophagy in yeast, going on to discover most of the Atg genes
(Takeshige et al., 1992; Thumm et al., 1994; Tsukada and Oh-
sumi, 1993). Meanwhile, other studies focused on the peculiar
morphology that some cells with autophagic activity show during
embryogenesis in lower eukaryotes. In 1977, Jacques Beaulaton
and Richard Lockshin elegantly demonstrated that in Lepidop-
tera the normal degeneration of intersegmental muscles, a cru-
cial step in insect metamorphosis, was accompanied by the
presence of autophagic vacuoles containing mitochondria
(Beaulaton and Lockshin, 1977). Similar evidence was found in
the regressing prothoracic and salivary glands of other insects,
including Drosophila (Scharrer, 1966; Schin and Laufer, 1973;
Schin and Clever, 1965). Increased autophagy in insect develop-
ment was associated with type II cell death, a form of nonapop-
totic programmed cell death involving excessive lysosomal
activity, formation of a large number of autophagosomes, and
presumed cell self-cannibalization (Baehrecke, 2003; Berry andDBaehrecke, 2007). In only a few cases, most notably in the devel-
oping nervous system, was such a death pathway found in
higher eukaryotes (Clarke, 1990; Hornung et al., 1989). These
studies suggested that autophagy has an important role in devel-
opment, although its specific functions remained unclear when
using morphologic analysis alone.
The eraof Atggenediscovery in lower eukaryoteswas followed
by in-depth investigation of the same process in vertebrates. In
1998, Beth Levine’s and Noboru Mizushima’s laboratories iso-
lated, in mammals, Beclin 1, and Atg5 and Atg12, respectively
(Liang et al., 1998; Mizushima et al., 1998b). Several mouse
models for Atg gene inactivation revealed interesting embryonic
phenotypes (Table 1, and listed in Table 1 of Levine andKroemer,
2008). In theory, there could be a link between apoptosis and au-
tophagy in these cases, suggesting that autophagy may trigger
cell demise upon strong environmental or extrinsic stress during
development, therebymatching the scenario believed to occur in
lower eukaryotes. However, the mechanisms and functions ofevelopmental Cell 15, September 16, 2008 ª2008 Elsevier Inc. 345
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Molecule and Role
in Autophagy
Mouse Model
Allele Symbol
and Type Type of Mutation
Key Aspects of
the Phenotype Reference
Ambra1: WD40
protein promotes
Vps34 complex
formation
(autophagosome
nucleation)
ambra1gt/gt
(all tissues)
gene trap allele:
Ambra1Gt(pGT1.8geo)1Fcec
gene trap insertion
predicted to cause
a 459 aa C-terminal
truncation; fusion
transcript, but no
protein, detected
decreased autophagy,
increased apoptosis
and cell proliferation
in embryonic brain;
neural tube defects
and embryonic
lethality
Fimia et al., 2007
Atg5: ubiquitin-like
protein covalently
modifies Atg12 and
binds Atg16L to
promote LC3-PE
recruitment to
autophagosome
membranes
(autophagosome
elongation)
atg5/
(all tissues)
knockout allele:
Atg5tm1Nmz
neomycin-resistance
(neo) gene replaces
the transcription start
site and first two
exons
perinatal death due
to nutrient and
energy depletion;
suckling defect;
increased apoptosis
in embryos
Kuma et al., 2004;
Qu et al., 2007
atg5/flox
(tissue-specific)
conditional allele:
Atg5tm1Myok (floxed)
loxP sites flank
exon 3 and neo
cassette; Cre
removes both
exon 3 and neo
Atg5tm1Myok combined
w/Tg(Nes-cre)1Kln
transgenic (Cre driver)
Cre expressed in
neuronal and glial
precursors by e11.0
(Nestin promoter)
ubiquitin-positive
inclusions in the
brains of e15.5
embryos and
postnatal mice,
early onset
neurodegeneration
Hara et al., 2006
Atg5tm1Myok combined
w/Tg(Zp3-cre)93Knw
transgenic (Cre driver)
Cre expressed in
female germline
(Zp3 promoter)
null embryos derived
from Atg5-deficient
eggs fail to develop
beyond the eight-cell
stage; Atg5-deficient
eggs fertilized by
wild-type sperm
are normal
Tsukamoto
et al., 2008
Atg5tm1Myok combined
w/Cd19tm1(cre)Cgn
transgenic (Cre driver)
Cre expressed
throughout B
lymphocyte
development
(Cd19 promoter)
the pro-B to pre-B
cell transition is
defective
Miller et al., 2008
Atg7: E1 ligase-like
protein activates
LC3-I and Atg12
(autophagosome
elongation)
atg7/
(all tissues)
conditional allele:
Atg7tm1.1Tchi
loxP sites flank
exon 14
excised during
oogenesis, this allele
results in a similar
phenotype to
Atg5tm1Myok / Tg(Zp3-
cre)93Knw as above
Komatsu
et al., 2005
atg7/flox
(tissue-specific)
combined w/Tg(Nes-
cre)1Wme transgenic
(Cre/Flp)
this Nestin-Cre, in
which Cre has a
nuclear localization
signal, drives variable/
mosaic activity by
e10.5, detectable in
all adult tissues
examined, including
the germline
progressive deficits
in motor function
and death a few
months after birth
Komatsu
et al., 2006346 Developmental Cell 15, September 16, 2008 ª2008 Elsevier Inc.
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Molecule and Role
in Autophagy
Mouse Model
Allele Symbol
and Type Type of Mutation
Key Aspects of
the Phenotype Reference
combined w/Tg(Pcp2-
cre)2Mpin transgenic
(Cre/Flp)
Cre expressed in
Purkinje cells
starting at P6 and
complete 2–3 weeks
postpartum
(L7/Pcp2 promoter)
degeneration of
the axon terminals
during postnatal
brain development
Komatsu
et al., 2007
Beclin 1/Atg6:
subunit of the
Vps34 complex
(autophagosome
nucleation)
becn1/
(all tissues)
knockout allele:
Becn1tm1Blev
neo replaces exons
1 and 2
abnormal ectodermal
layer with reduced
cavitation and early
embryonic lethality
Qu et al., 2003;
Qu et al., 2007
knockout allele:
Becn1tm1Htz
neo replaces exons
1 and 2 and 1.6 kb of
upstream sequence
widespread cell death,
reduced embryo size
Yue et al., 2003.
Allele symbols are standard according to http://www.informatics.jax.org.autophagy need further investigation. The question remains as
to whether autophagy constitutes an understudied form of cell
destruction or, alternatively or in parallel, whether it is a regulated
process capable of rapidly changing the cell in response to
environmental stimuli or intrinsic metabolic needs.
In order to function during embryogenesis (in proliferation,
migration, communication, differentiation, or death), cells un-
dergo phases of quiescence or enhanced metabolism. Thus,
they require dynamic tools to suddenly modify their organelle
or protein content so as to adapt rapidly and respond to adverse
conditions. Since development time is so rapid, proteasome-
mediated turnover of individual proteins is probably not sufficient
to effect the necessary cellular architectural changes. Auto-
phagy, which can mediate bulk protein and organelle turnover,
could therefore help to profoundly renovate cells or modify their
external appearance within a few hours. Therefore, a fuller
knowledge of autophagy in development might not only reveal
the evolutionary significance of this process, it may also explain
its roles in human pathologies.
Mouse Models of Autophagy
To establish the role of autophagy inmammalian development or
adult tissue homeostasis, various mouse and cellular models
have been generated by using multiple genetic approaches,
such as gene targeting, gene trapping, dysregulation in cell or tis-
sue culture of embryonic origin, tissue chimerism, and tissue-
specific conditional mutagenesis. The resulting developmental
phenotypes and the genetic features of the most relevant mouse
models are summarized in Table 1. Note that the complex pheno-
types we include here may not be uniquely related to autophagy
defects, but could also be due to the inactivation of nonautopha-
gic functions of these genes.
Atg1/Ulk1
The mouse ortholog of yeast Atg1 is Ulk1/Unc51.1 (Figure 1),
a serine/threonine kinase involved in the early steps of autopha-
gosome generation (Tomoda et al., 1999). Atg1 forms a complex
with other Atg regulatory proteins such as Atg13 and Atg17 (Ka-
mada et al., 2000; Tsukada and Ohsumi, 1993). Under nutrient-Drich conditions, i.e., upon autophagy inhibition, yeast Atg13 is
hyperphosphorylated, blocking its association with Atg1. How-
ever, under nutrient starvation, i.e., when autophagy activation
is required, Atg13 becomes partially dephosphorylated, with
subsequent Atg1-Atg13 interaction and the generation of the
autophagosome (Kamada et al., 2000). Ulk1 was the first au-
tophagy-related gene to be manipulated in a mouse system,
where it is expressed in granule cells in the cerebellar cortex.
Retroviral infection of immature granule cells with a dominant-
negative Ulk1 resulted in inhibition of neurite outgrowth in vitro
and in vivo (Tomoda et al., 1999, 2004). Moreover, infected neu-
rons failed to express any specific markers of neuronal differen-
tiation, suggesting that neurodevelopment was arrested early
(Tomoda et al., 1999). Ulk1 localizes to both axonal shafts
and growth cones of extending axons and is essential for neu-
rite extension and parallel fiber formation in cerebellar granule
neurons (Tomoda et al., 2004). An autophagy-independent
role for Ulk1 has been suggested in various species, such as
control of axonal elongation and branching in C. elegans (Ogura
et al., 1994) and mammals (Zhou et al., 2007). What seems to be
misregulated by Ulk1 manipulation is either the establishment
of a proper constellation of surface factors necessary for cell
migration and adhesion, or normal cell metabolism, essential
for an energy-consumptive cellular task such as axonal growth.
Interestingly, Ulk1 was found to localize to autophagic phago-
phores under starvation conditions, interacting with the Atg17
ortholog FIP200 (Hara et al., 2008). FIP200 itself was relocalized
upon starvation, switching from the cytoplasm to the phago-
phore (Hara et al., 2008). Given that FIP200 regulates diverse
cellular processes such as cell size, proliferation, migration,
and focal adhesion, the Ulk1-FIP200 interaction might have
other vital functions aside from autophagy.
Beclin 1
The autophagy-related gene becn1 (encoding Beclin 1; coiled-
coil, myosin-like BCL2-interacting protein) has been targeted
and inactivated in mice (Qu et al., 2003; Yue et al., 2003). Beclin
1 is the mammalian ortholog of yeast Atg6, a component of the
class III phosphatidylinositol-3-OH kinase (also known asevelopmental Cell 15, September 16, 2008 ª2008 Elsevier Inc. 347
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mals (Liang et al., 1999). It can inhibit tumorigenesis in vitro and
in vivo and is expressed at decreased levels in several human
cancers (Degenhardt et al., 2006; Liang et al., 1999; Mathew
et al., 2007; Qu et al., 2003; Yue et al., 2003). Beclin 1 is also de-
creased in degenerating neurons in Alzheimer’s disease tissues
and Beclin 1 heterozygous animals (becn1+/) develop an
Alzheimer’s-like pathology (Pickford et al., 2008). This protein in-
teracts with some members of the Bcl-2 protein family through
a BH3-like domain (see below; Maiuri et al., 2007a; Oberstein
et al., 2007; Pattingre et al., 2005).
What is the effect of becn1 disruption in mouse? Embryos
devoid of Beclin 1 (becn1/) exhibit a developmental delay cul-
minating in a severely reduced size at embryonic day 7.5 (e7.5)
(Table 1) (Yue et al., 2003). Although Beclin 1 expression was de-
tected in the extraembryonic visceral endoderm, this structure
forms properly, along with the head organization center, found
in its anterior part (anterior visceral endoderm). Analysis of in vitro
aggregates of becn1/ inner-mass-derived embryonic stem
cells (becn1/ embryoid bodies) and of themutant embryo itself
produced some surprising evidence (Figure 2) (Yue et al., 2003):
(1) becn1/ cells failed to form expanded cystic embryoid
bodies (hollow structures mimicking the blastocyst) due to a re-
duction in cell clearance at the core of the embryoid body
(Figure 2A), and (2) widespread cell death was visible in
becn1/ embryos at e6.5 and e7.5 (Figure 2B). becn1 and the
downstream autophagy gene atg5 (see below) are required for
the proper generation of ‘‘eat-me’’ and ‘‘come-get-me’’ engulf-
ment signals from the inner ectodermal apoptotic cells during
cavitation of the embryoid body via a mechanism involving au-
tophagy-dependent ATP energy homeostasis in dying cells (Qu
et al., 2007). Similarly, becn1/ e6.5 postimplantation
Figure 2. Developmental Phenotypes in Mice Lacking atg5,
beclin 1, or ambra1
(A) Representative images showing lack of cavity formation and accu-
mulation of TUNEL-positive cells at day 20 (20d) of development of
wild-type (wt) and atg5/ embryoid bodies (EBs) (excerpt from Qu
et al., 2007). Similar findings were obtained with becn1/ embryoid
bodies. Scale bar, 200 mm. H&E, hematoxylin and eosin staining;
TUNEL, terminal uridine deoxynucleotidyl transferase dUTP nick end
labeling for detection of DNA fragmentation (a hallmark of apoptosis).
(B) Becn1/ embryos at e6.5 fail to cavitate (left panels; red arrow la-
bels proamniotic cavity in wt embryo; sections stainedwith anti-Beclin
1 antibody) and have increased numbers of TUNEL-positive cells (right
panels; black arrow). Scale bar, 150 mm. (B.L., unpublished data.)
(C) Developing brains lacking ambra1 or atg5 stained positive for ubiq-
uitin (black arrows) at e11.5 and e15.5, respectively (excerpts from
Fimia et al., 2007 and Hara et al., 2006). Sections were stained with
an antibody directed against ubiquitin (anti-Ub). Scale bars, 10 mm
(e11.5) and 25 mm (e13.5/e15.5). Right subpanels reprinted by permis-
sion fromMacmillan Publishers Ltd: Nature, Hara et al., 441, 885–889,
copyright 2006.
embryos suffer from an accumulation of apoptotic cells
and formation defects of their proamniotic cavity
(Figure 2B). The cause of the phenotype of becn1/
embryoid bodies is the failure of the dying cells to display
the appropriate signals on their surfaces, which is neces-
sary for their recognition. Indeed, in mammalian develop-
ment the identity concept ‘‘autophagy = cell death,’’ often
proposed in lower eukaryotes, does not seem to be uni-
versally applicable. However, becn1 deficiency may also result
in early embryonic lethality through as yet unidentified autoph-
agy-independent functions in mammalian cells that parallel its
autophagy-independent roles in other membrane-trafficking
pathways in yeast.
Atg5 and Atg7
An important contribution to unraveling functions of autophagy in
vertebrate development came frommutations targeting two fun-
damental genes in this process, atg5 and atg7 (Table 1) (Ko-
matsu et al., 2005; Kuma et al., 2004). Atg5 and Atg7 function
in autophagosome expansion and completion (Figure 1) (Miz-
ushima et al., 1998a). Atg12, for which a targeted mouse model
is not yet available, is a small factor that covalently binds to Atg5.
The pathway of conjugation of Atg12 to Atg5 is similar to that of
ubiquitination; Atg12 is first activated by Atg7 (which acts as an
ubiquitin-activating enzyme E1) and then transferred to Atg10
(which has a similar function to E2) (Figure 1). A recent landmark
study demonstrated a critical role for atg5 in early mammalian
preimplantation development at the stage of transition from the
maternal to zygotic gene program (Tsukamoto et al., 2008). Em-
bryos derived from atg5/ oocytes fertilized by atg5/ sperm
(and thereby lacking maternal rescue effects) fail to develop be-
yond the four- and eight-cell stages. Presumably this is because,
without the autophagy machinery, maternal proteins and RNAs
cannot be degraded in order to activate zygotic transcription
and translation. However, in contrast to becn1/ embryos,
which die around day e7.5, atg5/ mice derived from atg5+/
offspring are born but die perinatally. Kuma et al. (2004) ob-
served that unsuckled atg5/ mice die earlier than wild-type
mice, whereas their survival can be slightly prolonged by forced
feeding. They also noticed that plasma and tissue amino-acid
concentrations in nonsuckling mutant mice are reduced relative348 Developmental Cell 15, September 16, 2008 ª2008 Elsevier Inc.
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pression of energy production that is reversible by forced feeding
(Kuma et al., 2004). Since the induction of autophagy is immedi-
ate and transient in the perinatal time period, reaching maximal
levels only 3 to 6 hr after birth and declining to basal levels within
a day or two, Mizushima and collaborators postulated that the
induction of autophagy following birth is required to provide
energy before nursing (Kuma et al., 2004). In another study,
examination of late embryonic tissues—such as the developing
neuroretina and lung—in atg5/ mice revealed the presence
of an increased number of apoptotic corpses (Qu et al., 2007),
thus supporting the involvement of autophagy in the removal of
apoptotic corpses during development.
An analogous early postnatal death, accompanied by reduced
pup size, has been described for atg7/ mice (Komatsu et al.,
2005). The reason for the reduced body size of atg7/ neonates
is unclear, but may be related to abnormal placental function or
to inefficient reutilization of nutrients during embryogenesis. It is
noteworthy that, in atg7/ tissues, an accumulation of ubiquitin
is detected on lipid droplet-like structures, membranous struc-
tures, and amorphous substances in the cytoplasm of neonatal
hepatocytes (Komatsu et al., 2005). The increase in ubiquitin
levels when autophagy is downregulated indicates (1) a role for
autophagy in targeting ubiquitinated proteins for degradation,
and/or (2) a possible role for the ubiquitin-proteasome system
in compensating for the lack of protein turnover that may lead
to accumulation of unfolded proteins during late development.
Due to the perinatal lethality of atg5 and atg7 mutant mice,
several tissue-specific conditional mouse models have been
generated for these two genes (see Table 1). Mice deficient in
atg5 or atg7 specifically in neural cells develop progressive def-
icits in motor function and die a few months after birth (Hara
et al., 2006; Komatsu et al., 2006). In atg5/ and atg7/ neu-
rons, as previously observed in the hepatocytes of atg7/
mice (see above), autophagy inhibition is accompanied by an
abnormal amount of ubiquitinated proteins that accumulate
and progressively form aggregates and inclusions. Although no
major morphological defects were reported during embryonic
nervous system development, the increase in ubiquitinated
proteins was detected from e15.5 onward in atg5/ neurons
(Figure 2) (Hara et al., 2006). Moreover, when atg7 is selectively
inactivated in the Purkinje cell subpopulation of the cerebellum
alone, degeneration of the axon terminals is observed (Table 1)
(Komatsu et al., 2007). Consistent with theUlk1-inactivation phe-
notype, axon terminals appear much more vulnerable than the
dendrites to autophagy impairment. Importantly, the analysis
of the phenotypes of mice lacking neuronal atg5 and atg7 high-
lighted that the physiological significance of autophagy can be
divided into two categories. ‘‘Baseline (or basal) autophagy’’ pre-
vents the accumulation of abnormal proteins during nervous sys-
tem development, whereas ‘‘induced autophagy’’ helps the cell
adapt to an adverse environment.
Atg5 has also been specifically knocked out in the heart and in
immune cells. In contrast to its effect in adult cardiomyocytes,
atg5 disruption during cardiogenesis does not induce cardiac
hypertrophy or dysfunction (Nakai et al., 2007). Even though
compensatory mechanisms may account for preventing the
pathological consequences of autophagy inhibition during de-
velopment, an important finding was observed in response toDblood pressure overload in postnatal mice. This insult produced
severe cardiac dysfunction after only one week, such as left ven-
tricular dilatation and death, associated with enhanced protein
synthesis and proteasome-dependent protein degradation (Na-
kai et al., 2007). In addition, inducible postnatal deletion of atg5 in
cardiomyoctes results in the rapid onset of heart failure (Nakai
et al., 2007), suggesting that autophagy is a beneficial pathway
responsible for cardiomyocyte remodeling during cardiogenesis
and essential for stress responses involved in cardiac homeosta-
sis. In the immune system, lymphoid precursor cells devoid of
atg5 were analyzed in chimeric mice by fetal liver reconstitution
after irradiation (Pua et al., 2007). A general reduction of both thy-
mocytes and B lymphocytes was observed, probably caused by
both a lowered lymphoid precursor activity and the inability of
these cells to undergo homeostatic proliferation (Pua et al.,
2007). In addition, selective apoptosis impaired the total number
of atg5-deficient CD8+ T cells (Pua et al., 2007). Finally, a specific
defect was observed in B cell development, at the pro-B to pre-B
cell transition, in mice with B lymphocyte-specific deletion of
atg5 (Miller et al., 2008).
LC3 and Atg4
Another molecule essential for autophagy is Atg8, whose mam-
malian ortholog is Microtubule-Associate Protein 1 Light Chain 3
(MAP1LC3/LC3) (Kabeya et al., 2000). Atg4/autophagin (present
inmouse in four different isoforms) cleaves LC3 into the cytosolic
version LC3-I. LC3-I is activated by Atg7, transferred to Atg3,
and then modified with a lipid attachment to become the mem-
brane-bound form LC3-II (Figure 1) (Ichimura et al., 2000; Kim
et al., 2002; Lang et al., 1998). This conversion is not only an es-
sential step of the membrane rearrangement dynamics during
the formation of autophagosomes, but it also represents a hall-
mark for detecting autophagy (Klionsky et al., 2008; Mizushima
et al., 2004). Both Atg4/autophagin (i.e., the isoform most widely
distributed in human tissues, Atg4C) and LC3 have been
knocked out in mouse (Cann et al., 2008; Marino et al., 2007). In-
terestingly, mutant atg4C/ mice develop normally (Marino
et al., 2007) and LC3-deficient mice display no developmental
abnormalities (Cann et al., 2008). Thus, neither protein seems
to be necessary for induction of the required level of autophagy
essential for the viability of neonatal mice. This is likely due to
a functional redundancy in the Atg4 family of cysteine protein-
ases and the presence of at least two murine forms of LC3
(LC3a and LC3b) (Cann et al., 2008).
Ambra1
Another striking example of how autophagy may influence em-
bryogenesis came from the gene trapping of activating molecule
in Beclin 1-regulated autophagy (Ambra1) (Fimia et al., 2007).
This molecule can bind to Beclin 1 upon autophagic stimuli,
thereby promoting the interaction between Beclin 1 and its target
kinase Vps34 (Figure 1). Ambra1 has no apparent orthologs in
lower eukaryotes. This protein is crucial for nervous system
development (Table 1) and is expressed from the first stages of
neurulation with high specificity for the neural plate. Its loss of
function leads to gross neural tube defects, such as exencephaly
and spina bifida, which culminate in death at around e16.5.
These findings open a new scenario for the putative tissue-spe-
cific regulation of autophagy. Specific regulation of autophago-
some formation via Beclin 1 recruitment into the class III PI3K
complex could conceivably take place in specific organs, dueevelopmental Cell 15, September 16, 2008 ª2008 Elsevier Inc. 349
Developmental Cell
Reviewto the variety of signaling networks responsible for tissue differ-
entiation during embryogenesis. In this case, the type of autoph-
agy would again be basal autophagy, which is responsible for
a proper recharge of cellular components, rather than induced
autophagy, which responds to specific environmental condi-
tions. Notably, ambra1mutant neuroepithelium at e11.5 is highly
enriched for ubiquitin (Figure 2), as described for the atg5
neuron-specific inactivation at e15.5 (see above).
Summary
The diverse phenotypes of different atg gene knockout mice
described here may reflect intrinsic differences in the develop-
mental effects of genes that function in different stages of
autophagy, the presence of varying levels of autophagy defi-
ciency with inactivation of different atg genes, autophagy-inde-
pendent effects of specific genes, or other as yet unidentified fac-
tors. However, taken together, these cellular systems andmouse
models suggest that autophagy is a finely regulated process that
appears to be essential for development. Interestingly, the com-
plex ontogenesis of the nervous system is particularly sensitive to
autophagy dysregulation, as revealed by the neural tube defects
and by the axonal growth and migration impairment upon inacti-
vation or downregulation of proautophagic genes.
Autophagy and Cell Death
Crosstalk between Cell Death and Autophagy
In lower eukaryotes, there are many examples of autophagy in
programmed cell death during embryogenesis, implying that
autophagic cell death is important for development (reviewed in
Baehrecke, 2003; Levine and Klionsky, 2004). All the mouse
models described seem to indicate that mammalian cells under-
going autophagy are generally healthy; they activate the pathway
as an adaptive response to extrinsic signals or they pursue base-
line (or induced) self-eating to allow ‘‘house cleaning’’ and mor-
phogenesis. The parallel with cell death, however, is not just
amisinterpretation. Indeed, autophagy and apoptosis are strictly
connected. Bcl-2 is an antiapoptotic factor regulating the mito-
chondrial response to cell death stimuli (for a recent review see
Youle and Strasser, 2008). Such Bcl-2 activity is controlled by
a specific pool of this molecule residing on the mitochondrial
membrane. By binding several proapoptotic or antiapoptotic
Bcl-2 family members (all containing a BH3 domain), Bcl-2 fine-
tunes mitochondrial membrane dynamics and triggers the re-
lease of cytochrome c and other apoptosis effectors from mito-
chondria. Beclin 1 was first described as a Bcl-2-interacting
cellular protein that plays a role in antiviral host defense (Liang
et al., 1998) and has since been shown to also contain a BH3
domain (reviewed in Levine et al., 2008). This interaction has sub-
sequently been linked to autophagy inhibition (Maiuri et al.,
2007a, 2007b; Pattingre et al., 2005;Wei et al., 2008), and the rel-
ative amounts of Beclin 1 and Bcl-2 (and also other Bcl-2 family
members, e.g., Bcl-XL) seem regulate the transition from cell
homeostasis to cell death. A nonmitochondrial pool of Bcl-2-
like molecules, namely those residing in the endoplasmic reticu-
lum, inhibit Beclin 1 function in autophagosome formation, and
Bcl-2/Beclin 1 complexes in the endoplasmic reticulum are dis-
rupted by JNK1-mediated Bcl-2 phosphorylation (Akao et al.,
1994; Krajewski et al., 1993; Wei et al., 2008). Thus, the cell’s de-
cision concerning death or survival is determined by the physio-
logical levels of autophagy, as partly determined by the relative350 Developmental Cell 15, September 16, 2008 ª2008 Elsevier Incamounts, subcellular localization, or phosphorylation status of
Bcl-2-like family members. Accordingly, the absence of autoph-
agy genes increases cell death during nutrient deprivation and
other forms of cellular stress.
By contrast, excessive, nonphysiological levels of autophagy
trigger autophagy-gene-dependent cell death (reviewed in
Maiuri et al., 2007b). Cells from Bax/Bak double knockout mice
resist apoptosis, but still undergo a nonapoptotic death after ex-
posure to death-inducing stimuli (Lum et al., 2005). Electron mi-
croscopic and biochemical studies reveal that death in these
cells is associated with autophagy, and can be blocked by
knockdown of Beclin 1 and Atg5 (Shimizu et al., 2004). This sug-
gests, in principle, that the Bcl-2 family of proteins not only reg-
ulates apoptosis, but also controls nonapoptotic programmed
cell death that depends on autophagy genes. Such an enhance-
ment of autophagy upon apoptosis inhibition has also been
found in cells where mitochondrial cell death is impaired by
downregulation of the apoptosome, a multimolecular complex
that regulates caspase activation in the presence of cytosolic cy-
tochrome c (structure and mechanisms reviewed by Riedl and
Salvesen, 2007; Schafer and Kornbluth, 2006). When, upon ex-
posure to specific apoptotic stimuli, the equilibrium of Bcl-2 fam-
ily members is prone to trigger cell death, cytochrome c is re-
leased by mitochondria; it then binds the apoptotic protease
activating factor Apaf1 and induces conformational changes of
its structure. This change induces Apaf1 binding with the initiator
caspase, caspase-9 (Casp9), which in turn can cleave and acti-
vate caspase-3 (Casp3). When death is induced and Casp3 is in-
hibited by broad-range or specific drugs (e.g., zVAD-fmk or qVD-
oph), autophagy occurs (Colell et al., 2007). This phenomenon
has been associated with a transient decrease in mitochondrial
mass. The specific autophagic degradation of damaged
mitochondria that have lost their membrane potential after cyto-
chrome c release could then spare a few intact mitochondria,
which enable cell survival. In another experimental approach,
the apoptosome was genetically inactivated by Apaf1 deletion
in proneural cells (Ferraro et al., 2008). In this case, autophagy
may also rescue the cell, by helping produce essential metabo-
lites for ATP generation. More recently, the upstream regulator of
apoptosis p53 has also been associated with autophagy regula-
tion. By experiments of deletion, depletion, or inhibition, it has
been shown that cytosolic p53 (and not nuclear p53) downregu-
lates autophagy (Tasdemir et al., 2008).
Two other factors play a clear role in autophagy-apoptosis
crosstalk. Damage-regulated autophagy modulator (DRAM)
is a p53 target that modulates autophagy (Crighton et al.,
2006). More specifically, DRAM is a lysosomal protein required
for a p53-positive effect on autophagy induction and is essential
for p53-mediated apoptosis. The contradictory results regarding
p53’s role in autophagy may be due to the two functions of p53
itself, as both nuclear regulator of gene activity and cytosolic
rheostat for various protein targets. Additionally, Atg5 has a
role in apoptosis, resembling the proapoptotic factor Bid. A trun-
cated form of Atg5, generated by calpain protease activity during
the execution of programmed cell death, translocates to the
mitochondria and accelerates its membrane permeability transi-
tion, thereby leading to the release of cytochrome c and the
enhancement of the apoptosome-dependent cell death (Yousefi
et al., 2006). A pioneer study by Baherecke and Lenardo (Yu.
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pase in the extrinsic death receptor pathway, can also regulate
autophagy. When Casp8 expression was reduced in cells ex-
posed to apoptosis-inducing stimuli, cell death surprisingly in-
creased, showing features of autophagy.
AutophagyMay AllowCell Survival in Cell DeathMutants
Developmental studies confirm the occurrence of autophagy in
cell death mutants. Mutant mousemodels for most proapoptotic
and antiapoptotic genes have been generated (for review arti-
cles, see Joza et al., 2002; Ranger et al., 2001; Schafer and Korn-
bluth, 2006). Among these, Apaf1 is one of the most relevant
(Cecconi et al., 1998; Yoshida et al., 1998). Two aspects of the
Apaf1 knockout phenotype are particularly noteworthy: the
nervous system hyperplasia and the persistence of interdigital
webs. Loss of interdigital cells in the mouse embryo, a paradigm
of cell death during development, is known to include an apopto-
tic mechanism. However, a necrotic-like morphology has been
described in the persistent interdigital webs in the Apaf1 mutant
limb buds (Cecconi et al., 1998; Chautan et al., 1999; Yoshida
et al., 1998). Web persistence can also be found in wild-type
limb explants subjected to apoptosis induction upon zVAD-
fmk-mediated caspase inhibition; similar explants from the
Apaf1/ embryos showed mottled chromatin condensation,
nuclear membrane detachment and rupture, dilated mitochon-
dria and cytoplasmic vacuoles, and sometimes external plasma
membrane rupture (Chautan et al., 1999). The sum effect of this
cellular response is a slow cavitation of the web, followed by its
final disappearance. The observed cell morphology could theo-
retically be due to a death mediated by excessive autophagy,
similar to what has been postulated in many circumstances for
lower eukaryote embryogenesis (type II cell death). Bax/Bak
double knockouts also exhibit interdigital web survival (Lindsten
et al., 2000). In contrast with the Apaf1 phenotype, this effect in
the Bax/Bak mutant is irreversible. In the mitochondrial death
pathway, Bax and Bak are defined as the gateway of apoptosis,
with these two factors playing a role upstream of mitochondrial
activation (Wei et al., 2001). Bax/Bak mutant cells (in which the
switch to apoptosis has been impaired) exposed to death-induc-
ing stimuli do not activate mitochondria at all; they not only sur-
vive, but are healthy. In Apaf1/ mice, vice versa, Bax/Bak and
other Bcl-2 family members enable cytochrome c release in re-
sponse to developmental signals from surrounding tissues; the
mitochondria start their depolarization program and autophagy
sustains cell survival until metabolites for energy production
are totally consumed and secondary cellular destruction takes
place. This represents an unsuccessful attempt at survival rather
than a death mechanism. In the nervous system, something very
similar has been observed. Cerebral cortices in forebrain over-
growth (fog) mice, which show reduced Apaf1 mRNA levels,
give rise to ectopic brain masses during development (Honar-
pour et al., 2001). These masses undergo intensive autophagy in
the postnatal phases of neurodevelopment (Moreno et al., 2006).
With respect to the autophagy-deficient phenotypes, we have
already describedwhat happens in atg5 or becn1mutant embry-
oid bodies or atg5 mutant retina (Qu et al., 2007). Autophagy
mediated by these two factors in dying cells is crucial for the
removal of dead corpses by the surrounding nonprofessional
phagocytes (see Figure 2). More recently, inhibition of autophagy
has also been shown to impair cell corpse removal in the devel-Doping avian retina (Melle´n et al., 2008). Therefore, what may at
first sight be interpreted as excessive cell death is, in fact, a de-
fect in cell signaling and cell corpse removal. Also in ambra1mu-
tant brains, apparent excessive apoptosis is observed. Many
TUNEL-positive cells accumulate in the caudal or rostral parts
of the forming neural tube, which is evident from e9.0 onward
(Fimia et al., 2007). Although it cannot be ruled out that defective
generation of engulfment signals contributes to the enhanced
cell death in this case, significantly, the onset of the phenotype
(hyperplasia of the neuroepithelium) occurs much earlier, at
around e7.0, when Apaf1 is not yet expressed in the embryo
and, consequently, the apoptosome cannot mediate mitochon-
dria-dependent programmed cell death. Excessive cell death
in ambra1mutant micemight be explained by the following alter-
native reasons: (1) autophagy defects in some subpopulations of
neuronal precursors might induce surrounding tissue to undergo
waves of apoptosis; (2) proneurons defective in autophagymight
undergo apoptotic cell death as described for some cell culture
systems; (3) supernumerary cells might be killed by programmed
cell death, which actively controls cell number in neurodevelop-
ment. Additional studies should elucidate the correct hypothesis
and whether it is related to the autophagic functions of Ambra1.
In light of recent evidence for an active role of basal autophagy
in neurodevelopment, some ‘‘apoptotic phenotypes’’ are worth
reevaluating: one example could be the c-Jun-NH(2)-terminal
kinase 1 and 2 double knockout embryo (Kuan et al., 1999;
Sabapathy et al., 1999). Embryos lacking both kinases (JNK1
and JNK2) die at around e11.0 and display an open neural
tube (exencephaly) at the hindbrain level with reduced apoptosis
in the hindbrain neuroepithelium at e9.25. In contrast, a dramatic
increase in cell death was observed one day later, at e10.5, in
both the hindbrain and forebrain. Which kind of cell death is
reduced and which kind is enhanced in this embryo? Could
two different cell death processes be impaired in the mutant?
Normal e9.25 fetuses contain a high proportion of apoptotic cells
in the hindbrain region, concentrated mostly at the edges of the
folding neural tube. This evidence has been reported by counting
condensed nuclei in the area and by TUNEL staining (Kuan et al.,
1999; Sabapathy et al., 1999). There are two possibilities: (1)
these cells lack basal autophagy, i.e., do not expose the appro-
priate come-get-me and eat-me signals and are not properly
phagocytosed; (2) they undergo type II nonapoptotic, autophagic
cell death in absenceof the JNKproteins. The increase in apopto-
sis is observed in these knockoutmodels at e10.5within the open
neural tube and atmorphogenetic apoptosis sites in the forebrain.
In this case, deregulated cell death might be a consequence of
either defective proapoptotic or proautophagic signals.
Although JNK proteins have been shown to regulate both
autophagy and apoptosis by a Casp8-dependent mechanism
(Yu et al., 2004), the mechanistic basis for the phenotype of
JNK1/JNK2 double knockout embryos remains unclear. Inter-
estingly, JNK1 appears to be essential for mediation of Bcl-2
phosphorylation, disruption of the Bcl-2/Beclin 1 complex, and
autophagy activation during starvation (Wei et al., 2008). Given
the parallels between the phenotypes of the JNK1/JNK2 and
Ambra1 mutant mice, it is tempting to speculate that JNK
proteins also regulate autophagy induction during neurodevel-
opment through effects on the Beclin 1/Ambra1 autophagy-
inducing complex.evelopmental Cell 15, September 16, 2008 ª2008 Elsevier Inc. 351
Developmental Cell
ReviewAn important open question is whether the excessive develop-
mental cell death observed in some of the mouse mutants here
described is a consequence or a secondary effect of defective
autophagy in vivo. Further studies about the roles of such pro-
cesses in the delicate balance of cell fate in development need
to be performed for an unequivocal answer.
Autophagy and Cell Proliferation
In several adultmousemodels of autophagy impairment, a signif-
icant dysregulation of the rate of cellular proliferation has been
observed. However, during development, the only example to
date of such alteration is represented by the ambra1 mutant
embryos, in which alterations in cell cycle progression were
detected at the beginning of neurulation and in ambra1-deficient
mouse embryonic fibroblasts (Fimia et al., 2007). Ambra1 is
mainly expressed in the neural plate at e7.0, the earliest stage
for detecting phenotypic abnormalities in the mutant embryos.
Although a complete uncoupling of the cell cycle defect from
the autophagy deficiency cannot be excluded, a link between
these two processes can be postulated. First, basal autophagy
may be relevant for recycling proteins essential in negative cell
cycle regulation; upon decrease in autophagy, those proteins
would not be available, inducing the cell cycle to speed up. Sec-
ond, when basal autophagy has been impaired, proneural cells
may not process, rearrange, or expose their own suitable mole-
cules for correct integration with the surrounding tissue. As a
consequence, without a clear commitment, and being prone to
division, they may continue to proliferate. Any disturbance of
the neural precursor cells at such an early stage may first have
consequences for proliferation and, subsequently, for cell migra-
tion and differentiation of the neuroepithelium. As described
above, alteration of the cell death program in neural precursors
induces a high rate of cell proliferation, resulting in a hyperplasic
brain, the formation of discrete ectopic brain masses, or both.
Also, defects in the cytoskeleton of proneural cells may lead to
defects in neural tube closure by impairing cell cycle regulation.
The findings fromDavid Rubinzstein’s laboratory are of particular
interest in this context (Ravikumar et al., 2005). Amechanistic link
has been hypothesized between dynein mutations and inclusion
formation in certain motor neuron diseases: dynein mutations
may impair autophagosome-lysosome fusion and the clearance
of aggregate-prone proteins, making neurons more susceptible
to proapoptotic insults. This hypothesis is based on the fact
that autophagosomes are transported along the neural axons
by the dyneinmotor complex on themicrotubuli to perinuclear re-
gionswhere lysosomes aremore abundant (Jahreiss et al., 2008).
A crucial role for thecytoskeleton in autophagosomefluxhas long
beenpostulated (Fass et al., 2006; Kochl et al., 2006) andautoph-
agy is impaired during mitosis (Eskelinen et al., 2002). A defect in
autophagosome formation could, conversely, potentially result
in dysregulated microtubular dynamics, which are a determinant
in cell cycle regulation.
Clearer effects of autophagy dysregulation on cell cycle are
evident in the homeostasis of adult tissues. Here, when autoph-
agy genes are deleted or downregulated, such as in hemizygous
conditions, a high incidence of tumors is observed in a wide
range of target tissues. Beclin 1, UVRAG, Atg4C, or Atg5 com-
plete or partial inactivation in certain cancers highlights each of
these molecules’ potential in tumor suppression, strongly sug-352 Developmental Cell 15, September 16, 2008 ª2008 Elsevier Inc.gesting that autophagy’s role in cancer has hitherto been under-
estimated. Becn1+/ mice are in fact viable, but they develop
a wide range of spontaneous malignancies with increased fre-
quency (Liang et al., 1999; Qu et al., 2003; Yue et al., 2003).
Atg4C/ mice show a higher incidence of chemically induced
fibrosarcomas as compared with their wild-type littermates
(Marino et al., 2007). The viable Bif-1/ mice, which do not ex-
hibit major abnormalities, show increased frequency of sponta-
neous lymphomas and solid tumors (Takahashi et al., 2007).
Bif-1 therefore joins the putative UVRAG-Beclin 1 complex as
a potential activator of autophagy (Figure 1) that can also be con-
sidered a bona fide tumor suppressor (along with UVRAG) (Liang
et al., 2006). Further studies involving mice lacking other compo-
nents of the Atg4 proteinase family or the Beclin 1 proautophagic
complex, and exhibiting mutations in the atg genes involved in
autophagosome elongation and completion, will help define
the role of each family member in vivo in both normal and path-
ological conditions, including cancer. Hence there is an urgent
need for understanding the mechanisms whereby autophagy
crosstalks with cell cycle regulation.
Autophagy and Differentiation
In principle, alterations in autophagy may influence cell fate dur-
ing mammalian development in several ways. First, autophagy
may, analogously to lower eukaryotes, destroy mammalian cells
by reducing the size of the cytosol, impairing protein synthesis,
engulfing energy-producing organelles, or stopping cell metabo-
lism. Second, autophagy may guarantee cell survival under dra-
matic conditions of mechanical or biochemical stress either
within the cell or when induced by the surrounding environment.
Third, autophagy may help the cell to rapidly and efficiently
change its cytosolic composition, accelerating routine protein
and organelle turnover and modifying the cell’s appearance in
terms of exposed receptors, transcriptional factors present in
the nucleus, and cytoskeletal dynamics. Of these three possibil-
ities, the latter is the most relevant for influencing cell-autono-
mous and/or regulated differentiation.
In at least three cases, the role of autophagy in this regard is
supported by experimental evidence. In the case of becn1/
mutant embryos, visceral endoderm development occurs, al-
though cells seem to have an abnormal morphology and devel-
opment is blocked after visceral endoderm formation (Yue
et al., 2003). Both the anterior-posterior and the dorso-ventral
axes of the mammalian embryo are established by a complex
set of interactions between embryonic (epiblast) and extraem-
bryonic tissues (which include the visceral endoderm among
others). At e5.0, at least two signaling centers are necessary
for the establishment of axes, one located in the anterior visceral
endoderm and the other in the epiblast (the node). The epiblast
induces the anterior visceral endoderm to form from the distal-
most visceral endoderm of the embryo (Rodriguez et al., 2005).
This signaling center expresses a unique set of molecular
markers (i.e., Hex, Lhx1, Cer1, and Lefty1) and is required for
specifying anterior neural identity. Later the node is induced in
the epiblast and is characterized by the expression of Nodal
and Wnt3, which in turn specify posterior cell fate. Accumulating
evidence indicates that reciprocal interactions between the epi-
blast and visceral endoderm are essential for establishing both
these signaling centers (reviewed in Takaoka et al., 2007). During
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ter implantation, the gastrulation and differentiation fate of the
embryo is therefore decided, and visceral endoderm, character-
ized by early expression of Beclin 1, is responsible for a related
set of events. The fact that visceral endoderm cannot go on to
develop in becn1/ mutant embryos may therefore derive
from a lack of signaling in the proper areas. In this specific stage
of embryogenesis, the autophagosomesmay selectively destroy
subcellular structures or clusters of proteins, allowing a fast re-
placement by the protein synthesis apparatus that involves
CAP-dependent and -independent translation or translational
control of mature mRNAs.
Similarly, the brain patterning of Ambra1 mutant embryos is
dysregulated during neural tube differentiation at e10.5 (Fimia
et al., 2007), with the morphogen sonic hedgehog (Shh) diffused
in the area of the neural tube floor plate rather than concentrated
in the notochord, a bona fide signaling center in neurogenesis
(Figure 3) (Marti and Bovolenta, 2002; Wilson and Maden,
2005). In normal development, the ventral-most part of the undif-
ferentiated neural tube (where Ambra1 is highly expressed) may
be responsible for producing specific receptors, transferring
them onto the membrane, and then exposing them. The spread
of Shh in the neural target field is influenced by the expression of
extracellular and transmembrane proteins, which can bind to it
and either restrict its diffusion or alter the rate of Shh degradation
(reviewed in Dessaud et al., 2008). Again, autophagosome
formation, mediated by Ambra1-dependent constitution of the
Figure 3. Autophagy-Dependent Regulation of Shh
Signaling
The morphogen sonic hedgehog (Shh) is involved in several as-
pects of vertebrate development. The model shown is specula-
tive, and autophagy-independent effects may also explain the
phenotypes of ambra1, becn1, and UVRAG targeted mutant
mice. (A) In wild-type embryos at e9.5, Shh expression is retained
within the notochord (Not). At the same developmental stage,
ambra1-deficient embryos show Shh expression diffused in the
ventral half of the neural tube (NT) and in the floor plate. (B) In
the absence of Ambra1, the interaction between Beclin 1 and
Vps34 is impaired and autophagy cannot proceed. In addition to
the control of Shh signaling during dorso-ventral (D/V) differentia-
tion of the neural tube, autophagy may be involved in regulating
the left-right (L/R) axis. In fact, in wild-type embryos, Shh also sig-
nals the establishment of the left-right axis in the node cells (see
text). In UVRAG mutant humans and Drosophila, the left-right
axis symmetry is disturbed, leading to heterotaxy. This could be
a consequence of incorrect Shh distribution within the node.
Beclin 1/Vps34 multimolecular kinase complex, might
regulate the proper receptor/ligand interaction, induc-
ing a fast cellular makeover in neural tube areas sub-
jected to strong cytosolic and nuclear rearrange-
ments.
Autophagy genes could also play a role in the spec-
ification of the left-right axis. In vertebrates, left-right
symmetry is determined in part by a flow of Shh in
the left cells of the node during gastrulation, inducing
left-gene expression in the left part of the primitive
streak. Ciliary movements of node cells have been
linked to this asymmetric concentration of Shh (Hiro-
kawa et al., 2006). Interestingly, the factor UVRAG (an-
other component of the dynamic Beclin 1/Vps34 com-
plex) (Liang et al., 2006) is mutated in a human case of abnormal
left-right axis formation, resulting in heterotaxy andmultiple mal-
formations (Iida et al., 2000). Since UVRAG is also expressed
during embryonic life in presomitic stages, this phenotype could
also be related to an impairment of Shh distribution in the node,
caused by a decreased rate of autophagosome formation and
a defective cell makeover in those cells (Figure 3). Notably, a sim-
ilar phenotype in Drosophila has been identified, upon mutation
of an UVRAG ortholog gene (reported in He and Overdahl, 2007).
Another relevant role of Shh during embryogenesis is the estab-
lishment of the antero-posterior axis of the limb (Laufer et al.,
1994). Interestingly, the first analysis of atg5 embryonic expres-
sion, performed in 1998 in Peter Gruss’ laboratory, showed high
levels of atg5 (originally termed paddy) mRNA in the zone of po-
larizing activity (ZPA), the area of the limb bud responsible for an-
tero-posterior axis formation (Pires da Silva and Gruss, 1998).
Conclusion
The importance of autophagy during development has been
highlighted by a number of approaches in lower eukaryotes,
from yeast toC. elegans,Drosophila andD. discoideum. In these
organisms, autophagy is a relevant stress response, and the de-
velopmental stages involving highly stressful conditions, such as
yeast sporulation or insect metamorphosis, activate autophagic
pathways. Autophagy as a cell death mechanism, characterized
by lysosomal activation and cell vacuolization, has also been
widely investigated. However, only in the last decade haveDevelopmental Cell 15, September 16, 2008 ª2008 Elsevier Inc. 353
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thanks to the elucidation of the major molecular mechanisms of
autophagy. Given the phenotypes observed in lower eukaryotes,
it seemed at one point that autophagymight be a stress response
or a death mechanism in mammals. Instead, new findings in
becn1, ambra1, atg5, and atg7, and other atg gene inactivation
during development now indicate that autophagy is an important
prosurvival mechanism andmay act in renovating the cell cytosol
by degrading bulk cytoplasm, specific long-lived proteins, or
damaged mitochondria. Furthermore, autophagy may help the
cell signal its condition to the surroundings or rapidly modify its
protein content to better respond to extrinsic stimuli. Notably,
the definition of autophagy as merely a programmed cell death
pathway has also been recently called into question inDrosophila
(Akdemir et al., 2006; Martin and Baehrecke, 2004; Juha´sz et al.,
2007). Histolysis of the salivary gland, a classical example of
autophagy-dependent cell death in Drosophila, requires Dark
and Dronc, two orthologs of vertebrate Apaf1 and Casp9. This
implies that autophagy per se is not the ‘‘lethal event’’ mediating
histolysis of this organ. Instead, the induction of autophagy may
lie upstream of, or parallel to, the apoptosome.
Another ground-breaking finding is that the nervous system is
a preferential target for uncovering autophagy abnormalities,
perhaps due to the existence of a neurospecific autophagy
apparatus in the developing central nervous system. However,
another cause may be the high sensitivity of the neural precursor
cells to any changes in their protein or organelle content prior to
(or at the beginning of) their complex differentiation.
Studying autophagy in mouse models during development
may also have important consequences for medicine. Neural
tube defects, such as spina bifida or exencephaly, are common
congenital malformations leading to infant mortality or severe
disability. Despite the multifactorial etiology of neural tube de-
fects, the discovery of an orchestrated control of both apoptotic
cell death and basal autophagy for regulating the correct mor-
phogenesis and cell number in the developing central nervous
system may reveal novel target factors for diagnostic and thera-
peutic purposes. Similarly, there is a need to further evaluate the
contribution in humans of autophagy dysregulation to early
developmental defects, e.g., in preimplantantion development
abnormalities and in proamniotic cavity formation, where murine
Atg5 and Beclin 1, respectively, are important factors.
The landmarkdiscovery of the roles that autophagyplays in de-
velopment may have implications for cancer. In light of autopha-
gy’s role in tumorigenesis, it may be possible to pinpoint single
components of the autophagy pathway that characterize, when
mutated, the embryonic origin of various tumors. Admittedly,
much work needs to be done in defining more fully the mecha-
nisms that autophagy may use in cell cycle regulation and tumor
suppression. One thing remains clear, however: the putative
pharmacological modulation of genes in these processes could
represent a novel strategy for treating a wide range of tumors.
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